Diabetes Autoantibodies Mediate Neural- and Endothelial Cell- Inhibitory Effects Via 5-Hydroxytryptamine- 2 Receptor Coupled to Phospholipase C/Inositol Triphosphate/Ca2+ Pathway
Journal Title: Journal of Endocrinology and Diabetes - Year 2017, Vol 4, Issue 4
Abstract
Aims: To identify the G-protein coupled receptor(s) on neuroblastoma and endothelial cells which mediate neural- and endothelial cellinhibitory effects in plasma autoantibodies from a subset of older type 2 diabetes with neurologic and vascular co-morbidity. To determine the mechanism(s) of neurite retraction induced by diabetic pathologies’ auto antibodies. Methods: Protein-A eluates from plasma of 11 diabetic patients having nephropathy, moderate-severe obesity and/or complications in which increased inflammation plays a role (depression, Parkinson’s disease, atrial fibrillation, obstructive sleep apnea) were tested for neurite retraction and decreased survival in N2A neuroblastoma cells, and decreased survival in pulmonary artery endothelial cells. Specific antagonists of G protein coupled receptors belonging to the G alpha q subfamily of hetero trimetric G proteins or the phospholipase C/inositol triphosphate/Ca2+ pathway were tested for modulatory effects on diabetic pathologies’ autoantibody-induced N2A neurite retraction, or cell survival. Results: Co-incubation with specific antagonists of the 5-hydroxytryptamine- 2A receptor significantly prevented acute N2A neurite retraction induced by 50-100 nM concentrations of diabetic pathologies’ autoantibodies. Protection against neurite retraction (M100907> spiperone> ketanserin) closely paralleled the antagonists’ potency order at the 5-HT2-AR. Neuroblastoma or endothelial cell death (after 24 hours incubation) with 50-100 nM autoantibodies was completely or nearly completely (91%) prevented by co-incubation with 200 nM M100907, a highly selective 5-HT2-AR antagonist. Alpha-1 adrenergic, angiotensin II, metabotropic glutamate 5, or endothelin A (100 nM-10μM) receptor antagonists did not substantially inhibit autoantibody-induced cell death. The intracellular calcium chelator (BAPTA-AM, 50 μM) and inhibitors of the inositol triphosphate (IP3) receptor (2-APB, 50μM), and phospholipase C-gamma (U73144, 1μM) each significantly protected against autoantibody-induced acute N2A neurite retraction. Conclusion: These data suggest that neural- and endothelial- inhibitory effects in autoantibodies from older adult diabetes with nephropathy and obesity/inflammation-associated complications are mediated by agonist autoantibodies directed against the 5-hydroxytryptamine 2 receptor positively coupled to the phospholipase C/inositol triphosphate/ cytosolic Ca2+ release pathway.
Authors and Affiliations
Mark B. Zimering
Keywords
Related Articles
- EP ID EP333825
- DOI 10.15226/2374-6890/4/4/00184
- Views 86
- Downloads 0
Diabetic Lower Extremity Ulcers and Hyperbaric Oxygen Therapy
Diabetic wounds are a worldwide problem with significant effects for those whose wounds fail to heal as expected and who go on to require amputation. Standard care is generally effective in healing diabetic ulcers, but i...
Hypercalcemia following Alfacalcidol for Post-Surgical Hypoparathyroidism-An Underestimated Complication?
Background: Post operative hypocalcemia is a common complication of thyroid and parathyroid surgery and is treated with calcium and/or active Vitamin D supplements, such as alfacalcidol. Although reportedly uncommon, we...
Factors Associated With Glycemic Control among Type 2 Diabetes Patients Attending Mathari National Teaching Hospital, Nairobi Kenya
Introduction: Type 2 Diabetes mellitus is chronic metabolic disorder characterized by hyperglycemia resulting from insulin secretion, insulin action, or both and accounts for over 95% cases globally. Uncontrolled diabete...
Pentraxin 3 as A Cardiovascular Marker in Primary Hyperparathyroidism
Aim: Pentraxin 3 (PTX3) is an acute-phase glycoprotein, which is increased in patients with cardiovascular disease (CVD) and considered as a predictor of CVD in the general population. Accumulating evidence suggests that...
Maternal Diabetes Mellitus – Risk Factor for Fetus and Infant
Diabetes during pregnancy may occur as pregestational or gestational diabetes mellitus. Throughout gestation there is a close relationship between maternal and fetal blood glucose concentrations. Maternal hyperglycemia l...